Hiroki Numata

Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma following tyrosine kinase inhibitor treatment for chronic myelogenous leukemia.

K. Ando, Koshi Matsumoto, N. Nakamura, 2017, Journal of clinical and experimental hematopathology : JCEH.

The Effect of Roxadustat on Transfusion-Dependent Myelodysplastic Syndrome Complicated by Chronic Kidney Disease

D. Furuya, K. Ando, N. Goto, 2021, Case Reports in Oncology.

Erratum to: Successful bypass surgery for esophageal carcinoma under adequate factor XIII/13 replacement therapy in a case of intractable autoimmune hemorrhaphilia due to anti-Factor XIII/13 antibodies

K. Ando, S. Ozawa, A. Ichinose, 2016, International Journal of Hematology.

Successful bypass surgery for esophageal carcinoma under adequate factor XIII/13 replacement therapy in a case of intractable autoimmune hemorrhaphilia due to anti-Factor XIII/13 antibodies

K. Ando, S. Ozawa, A. Ichinose, 2015, International journal of hematology.

Clinical outcome of Epstein–Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era

K. Ando, N. Nakamura, K. Ohmachi, 2014, Cancer science.

Fetal hemoglobin level predicts lower-risk myelodysplastic syndrome.

K. Ando, E. Kikkawa, M. Toyosaki, 2022, International journal of hematology.

Refractory acute promyelocytic leukemia successfully treated with combination therapy of arsenic trioxide and tamibarotene: A case report

K. Ando, H. Matsushita, H. Kawada, 2016, Leukemia research reports.

An Acceptable Incidence of Infusion Site Reactions after Subcutaneous Bortezomib Administration in the Upper Arm in Japanese Patients with Multiple Myeloma

Hiroki Numata, T. Sasao, K. Tsuboi, 2014, Acta Haematologica.